Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.54 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.54 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.54 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | HPRT1 | P00492 | 3/20 | 0.46 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.35 |
| ▸ | FYN | P06241 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | AHR | P35869 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14718718 | 0.96 | HPRT1 (0.54) | ALDH1A1HSD17B10CYP1B1HIF1ACYP2A6 | |
| SCHEMBL27904402 | 0.86 | ALDH1A1 (0.46) | ALDH1A1HSD17B10CYP1B1HIF1ACYP2A6 | |
| SCHEMBL18221905 | 0.82 | ALDH1A1 (0.52) | ALDH1A1HSD17B10CYP1B1HIF1ACYP2A6 | |
| SCHEMBL25252116 | 0.80 | ALDH1A1 (0.40) | ALDH1A1HSD17B10CYP1B1HIF1ACYP2A6 | |
| SCHEMBL28294913 | 0.80 | ALDH1A1 (0.41) | ALDH1A1HSD17B10CYP1B1HIF1ACYP2A6 | |
| SCHEMBL2846828 | 0.77 | ALDH1A1 (0.44) | ALDH1A1HSD17B10CYP1B1HIF1ACYP2A6 | |
| SCHEMBL24252 | 0.77 | CYP2A6 (0.41) | ALDH1A1HSD17B10CYP1B1HIF1ACYP2A6 | |
| SCHEMBL12474905 | 0.75 | ALDH1A1 (0.44) | ALDH1A1HSD17B10CYP1B1HIF1ACYP2A6 | |
| SCHEMBL5028398 | 0.75 | ALDH1A1 (0.44) | ALDH1A1HSD17B10CYP1B1HIF1ACYP2A6 | |
| SCHEMBL15937996 | 0.75 | ALDH1A1 (0.46) | ALDH1A1HSD17B10CYP1B1HIF1ACYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 284 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160240782-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2016-08-18 | — | — | US | claimed |
| EP-2307520-B1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2015-11-11 | — | — | EP | claimed |
| US-9066410-B2 | Organic electronic device | MERCK PATENT GMBH (DE) | 2015-06-23 | — | — | US | claimed |
| US-8361638-B2 | Fluorine derivatives for organic electroluminescence devices | MERCK PATENT GMBH (DE) | 2013-01-29 | — | — | US | claimed |
| EP-2260023-B1 | FLUORENE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2012-04-25 | — | — | EP | claimed |
| JP-2011528324-A | — | — | 2011-11-17 | — | — | JP | claimed |
| US-20110140043-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2011-06-16 | — | — | US | claimed |
| EP-2307520-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | Merck Patent GmbH (DE) | 2011-04-13 | — | — | EP | claimed |
| US-20110037027-A1 | FLUORINE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2011-02-17 | — | — | US | claimed |
| EP-2260023-A1 | FLUORINE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENCE DEVICES | Merck Patent GmbH (DE) | 2010-12-15 | — | — | EP | claimed |
| WO-2010094378-A1 | ORGANIC ELECTRONIC DEVICE | MERCK PATENT GMBH (DE) | 2010-08-26 | — | — | WO | claimed |
| WO-2010006680-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2010-01-21 | — | — | WO | claimed |
| WO-2009124627-A1 | FLUORINE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2009-10-15 | — | — | WO | claimed |
| US-20030092637-A1 | Novel compounds | XYLOGEN AB (SE) | 2003-05-15 | — | — | US | claimed |
| US-20240244957-A1 | FORMULATION OF AN ORGANIC FUNCTIONAL MATERIAL | Merck Patent KGaA (DE) | 2024-07-18 | — | — | US | disclosed |
| WO-2024126635-A1 | FORMULATION OF AN ORGANIC FUNCTIONAL MATERIAL | MERCK PATENT GMBH (DE) | 2024-06-20 | — | — | WO | disclosed |
| EP-4340969-A1 | METHOD FOR THE CONTINUOUS PURIFICATION OF AT LEAST ONE FUNCTIONAL MATERIAL AND DEVICE FOR THE CONTINUOUS PURIFICATION OF AT LEAST ONE FUNCTIONAL MATERIAL | Merck Patent GmbH (DE) | 2024-03-27 | — | — | EP | disclosed |
| US-4791233-A | ANTITUMOR AGENTS | BURROUGHS WELLCOME CO. (US) | 1988-12-13 | — | — | US | disclosed |
| US-4791232-A | ANTITUMOR AGENTS | BURROUGHS WELLCOME CO. (US) | 1988-12-13 | — | — | US | disclosed |
| US-4791231-A | ANTITUMOR AGENTS | BURROUGHS WELLCOME CO. (US) | 1988-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030092637-A1 | Novel compounds | ENTPD5, G6PD, G6PC1 | ALDH1A1 986/4885HSD17B10 859/4885CYP1B1 1327/4885 |
| US-20110140043-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICE | L1CAM, SLCO4C1, GJA1 | ALDH1A1 604/4885HSD17B10 2499/4885CYP1B1 570/4885 |
| US-20160240782-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICE | L1CAM, SLCO4C1, GJA1 | ALDH1A1 604/4885HSD17B10 2499/4885CYP1B1 570/4885 |
| US-20110037027-A1 | FLUORINE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENCE DEVICES | SLCO4C1, CTCF, AFF2 | ALDH1A1 2171/4885HSD17B10 3576/4885CYP1B1 2195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.